Hangzhou Jiuyuan Gene Engineering Co.,Lt is a leading biopharmaceutical company that has pioneered the development of several innovative products in China, including rhG-CSF (filgrastim), Liraglutide (recombinant), Enoxaparin sodium, Fulvestrant, Interleukin-11, Palonosetron Hydrochloride, rhBMP-2, and Fosaprepitant dimeglumine. The company is committed to advancing healthcare through its extensive product pipeline, which features promising compounds such as Semaglutide (recombinant), Semaglutide intermediate, Recombinant Hyaluronidase, Pegfilgrastim, Dulaglutide, Avatrombopag maleate, Daratumumab, Romosozumab, amylin analog, and CD47-SIPR.

Services include:
- Biologics
- Product development
- Contract manufacturing
- Quality assurance

Hangzhou Jiuyuan Gene Engineering Co.,Lt continues to excel in the pharmaceutical industry by providing high-quality biopharmaceutical products and services that support healthcare advancements. For more information, please visit china-gene.com.